WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their GYRE stock forecasts and price targets.

Forecast return on equity

Is GYRE forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is GYRE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

GYRE revenue growth forecast

How is GYRE forecast to perform vs Biotechnology companies and vs the US market?
Company
-23.95%
Industry
37.04%
Market
9.92%
GYRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GYRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GYRE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GYRE$16.33N/AN/A
MORF$27.98$56.00+100.14%Strong Buy
PTGX$24.66$39.00+58.15%Strong Buy
NMRA$9.06$26.50+192.49%Strong Buy
KURA$19.00$31.75+67.11%Strong Buy

Gyre Therapeutics Stock Forecast FAQ

What is GYRE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GYRE) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.

What is GYRE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GYRE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.